0001062993-24-003491.txt : 20240216 0001062993-24-003491.hdr.sgml : 20240216 20240216172620 ACCESSION NUMBER: 0001062993-24-003491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feike Jeffrey L. CENTRAL INDEX KEY: 0002011766 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41002 FILM NUMBER: 24649686 MAIL ADDRESS: STREET 1: C/O TEVOGEN BIO HOLDINGS INC. STREET 2: 15 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tevogen Bio Holdings Inc. CENTRAL INDEX KEY: 0001860871 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981597194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 646-807-8832 MAIL ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Semper Paratus Acquisition Corp DATE OF NAME CHANGE: 20210505 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-02-14 0001860871 Tevogen Bio Holdings Inc. TVGN 0002011766 Feike Jeffrey L. C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BLVD, STE 410 WARREN NJ 07059 1 0 0 0 0 Common Stock 2024-02-14 4 A 0 581771 A 581771 D On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer. /s/ Kirti Desai, Attorney-in-Fact 2024-02-16